Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
-
Mawer Offers New Global Credit Opportunities Fund
-
Nano Dimension Filed for 2nd Patent for a Unique Large Language Model (LLM)
-
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology
-
Launching our most comprehensive test and expanding into new global markets
-
Robotic Sortation Just Got Better with Berkshire Grey 4th Generation Robotic Sortation Solution
-
KL Software Technologies Builds Data-Driven, Bilingual Intranet for International Law Firm Fasken Martineau DuMoulin LLP
-
Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
-
Ouinex Secures VASP Registration from Polish Regulator KNF Paving the Way for European Expansion
-
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings
-
Brain Training Improves Social Determinants of Health
-
North American Construction Group Ltd. Announces Award of Regional Services Contract
-
Aqua Security Named Leader and Fast Mover for Cloud Workload Security (CWS)
-
Dickey’s Barbecue Pit Partners with Red Bull
-
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Merus to Participate in Upcoming Investor Conferences
-
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
-
Treasure Global to Report Second Quarter Fiscal Year 2024 Results on February 14, 2024
-
Independent tests confirm 30x performance boost for secure remote access
-
USGI Medical Receives FDA Approval to Conduct Pivotal Study of the POSE2.0® Incisionless Weight Loss Procedure for Primary Obesity
-
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
Constellium to Report Fourth Quarter and Full Year 2023 Results on February 21, 2024
-
Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
-
Cyber Acoustics to Attend TCEA 2024, Will Showcase New Webcam for Virtual Learning as well as Line of Durable Headsets for Any Classroom Need
-
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
-
Westwood Holdings Group, Inc. to Host Fourth Quarter and Fiscal Year 2023 Conference Call/Webcast
-
RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
Attestiv Debuts Game-Changing Online Tools to Detect AI Fakery and Authenticate Critical Media
-
Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
Alm. Brand A/S - Change to the Board of Directors of Alm. Brand A/S
-
TransUnion Global Study Finds More Than Half of U.S. Consumers Use Credit Monitoring to Open New Credit Accounts
-
ZyVersa Therapeutics Highlights Publication Indicating That Inflammasome NLRP3-Mediated Inflammation in Obese Children Leads to Insulin Resistance and Risk of Complications Such as Type 2 Diabetes
-
Annual general meeting of Ringkjøbing Landbobank A/S
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Fairfax Announces Acquisition of Additional Orla Shares
-
Ingredion Named One of Fortune Magazine’s World’s Most Admired Companies for 14th Year
-
Neurimmune to regain global rights to brain amyloid depleter for the treatment of Alzheimer’s disease
-
Novo Nordisk files annual report with the SEC
-
Fancamp Provides Corporate Update
-
Survey: General Counsel Expect Significant Increase in Technology Investments and Artificial Intelligence Adoption
-
Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-Out
-
Protara Therapeutics to Participate in Upcoming Investor Conferences
-
AYR Announces Closing Date for Previously Announced Plan of Arrangement is targeted for on or around February 7, 2024
-
HPQ Signs NDA With Industrial Group to Explore Fumed Silica Plant Joint Venture
-
Biogen to Realign Resources for Alzheimer's Disease Franchise
-
Biogen to Realign Resources for Alzheimer's Disease Franchise
-
Agrify Receives Positive Nasdaq Listing Determination
-
Surge Copper Intersects 418 metres grading 0.38% CuEq including 40 metres grading 0.47% CuEq at the Berg Deposit
-
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
CoreCard Corporation Schedules Fourth Quarter 2023 Earnings Release and Conference Call
